Hao Cui

Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy

Immune Cells in Hyperprogressive Disease under Immune Checkpoint-Based Immunotherapy

Lung metastasis and lymph node metastasis are risk factors for hyperprogressive disease in primary liver cancer patients treated with immune checkpoint inhibitors